Literature DB >> 19158577

Traumatic graft dehiscence after anterior lamellar keratoplasty.

Pawan Prasher1, Orkun Muftuoglu, V Vinod Mootha.   

Abstract

A 64-year-old man underwent anterior lamellar keratoplasty using the Melles technique for corneal scar secondary to healed bacterial keratitis in the left eye. Two months postoperatively, the patient presented with blurry vision in the left eye after a fall in the bathroom. The uncorrected visual acuity was 20/400 in the left eye, and the external examination showed periorbital swelling with ecchymosis. Slit-lamp examination revealed an absent graft, a circular crater in the center, and a fragment of suture on the temporal edge of the crater. The Seidel test was negative, and there was no sign of infection. The anterior segment optical coherence tomography showed intact residual stroma with slight forward protrusion. The patient underwent repeat anterior lamellar corneal transplantation with improvement in uncorrected visual acuity of 20/100 and best spectacle-corrected visual acuity of 20/70 in the left eye 3 months postoperatively.

Entities:  

Mesh:

Year:  2009        PMID: 19158577     DOI: 10.1097/ICO.0b013e318187547b

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

Review 1.  Safety of Cultivated Limbal Epithelial Stem Cell Transplantation for Human Corneal Regeneration.

Authors:  J Behaegel; S Ní Dhubhghaill; C Koppen; N Zakaria
Journal:  Stem Cells Int       Date:  2017-03-30       Impact factor: 5.443

2.  Posttraumatic deep anterior lamellar keratoplasty dehiscence: Descemet's resistance.

Authors:  Meena Lakshmipathy; Prabhat Nangia; Rashima Asokan
Journal:  Indian J Ophthalmol       Date:  2020-07       Impact factor: 1.848

3.  Traumatic Wound Dehiscence after Keratoplasty: Characteristics, Risk Factors, and Visual Outcome.

Authors:  Mohamed Bahgat Goweida; Hany Ahmed Helaly; Alaa Atef Ghaith
Journal:  J Ophthalmol       Date:  2015-07-09       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.